Kidney & Urology Foundation of America
Kidney & Urology Foundation of America
SAVE THE DATE:
Support Walk the Walk
New York Walk the Walk

October 31, 2010 - Central Park
REGISTER ONLINE NOW!
join us on Facebook
Join KUFA today
and become an essential part of the fight to save and improve lives. There are no fees for patients, family and friends to get connected!

 

Patient Resources


Therapeutic Areas: Oncology | Family Medicine

Adenocarcinoma Clinical Trials


A listing of Adenocarcinoma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Alabama

Birmingham : University of Alabama at Birmingham

A clinical trial to evaluate treatments using live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001 and laboratory biomarker analysis for patients with Cervical Cancer

Huntsville : Clearview Cancer Institute

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Huntsville : Clearview Cancer Institute

Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer

Arizona

Phoenix : Translational Genomics Research Institute (TGen)

A clinical trial seeking patients for a research study for the treatment of Solid Tumors

Phoenix : Saint Joseph's Hospital and Medical Center

A clinical trial to evaluate treatments using live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001 and laboratory biomarker analysis for patients with Cervical Cancer

Scottsdale : Scottsdale Healthcare

A clinical research study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody for the treatment of Malignant Solid Tumors

Scottsdale : Research Site

A clinical trial seeking patients for a research study for the treatment of Renal Cell Adenocarcinoma, Clear Cell Renal Carcinoma, Clear Cell Renal Cell Carcinoma or Renal Cell Carcinoma

Scottsdale : Mayo Clinic Arizona

A Phase 1 clinical study for patients with Advanced Pancreatic Cancer, Metastatic Pancreatic Cancer or Pancreatic Adenocarcinoma

Scottsdale : Mayo Clinic Arizona - Cancer Clinical Research Unit

Patients are needed to participate in a clinical research study evaluating CDX-1127

Scottsdale :

Patients are needed to participate in a clinical research study evaluating Ferumoxytol followed by MM-398

Tucson : University of Arizona Health Sciences Center

A clinical research study for the treatment of Metastatic Pancreatic Adenocarcinoma

Tucson : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Tucson : Synta Pharmaceuticals InvestigationalSite

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

California

Alhambra : Central Hematology Oncology Medical Group, Inc.

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Bakersfield : Comprehensive Blood and Cancer Center

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Corona : Wilshire Oncology Medical Group, Inc.

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Duarte : City of Hope

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Duarte : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Fullerton : Saint Jude Heritage Healthcare

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Hollywood : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Long Beach : Pacific Shores Medical Group

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Los Angeles : Cedars Sinai Medical Center

A clinical research study of CEP-37250/KHK2804 for the treatment of Solid Tumour, Adenocarcinoma of the Colorectal or Adenocarcinoma of the Pancreas

Los Angeles : Cedars Sinai Medical Center SC

A clinical research study of LDE225 and BKM120

Los Angeles : UCLA Community Oncology Practice

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Los Angeles : Comprehensive Hematology Oncology Centers, Inc.

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Los Angeles : USC Norris Comprehensive Cancer Center

A Phase 1 clinical study for patients with Advanced Pancreatic Cancer, Metastatic Pancreatic Cancer or Pancreatic Adenocarcinoma

Los Angeles : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Los Angeles : USC Norris Comprehensive Cancer Center

Patients are needed to participate in a clinical research study evaluating orteronel and laboratory biomarker analysis for the treatment of Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Palo Alto : Stanford University Medical Center

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Pomona : Wilshire Oncology Medical Group, Inc.

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Redondo Beach : Cancer Care Associates Medical Group

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Redondo Beach : Pacific Shores Medical Group

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Sacramento : UC Davis Comprehensive Cancer Center

Alisertib and Gemcitabine Hydrochloride in Treating Patients With Solid Tumors or Pancreatic Cancer

Sacramento : UC Davis Comprehensive Cancer Center

Irinotecan and Alisertib in Treating Patients With Advanced Solid Tumors or Colorectal Cancer

Sacramento : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

San Diego : Sharp Health Care

A clinical trial to evaluate treatments for patients with Colorectal Cancer

San Francisco : University of California San Francisco UCSF (SC)

A clinical research study of LDE225 and BKM120

San Francisco : UCSF-Mount Zion

A clinical trial to evaluate treatments using live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001 and laboratory biomarker analysis for patients with Cervical Cancer

San Jose : San Jose Medical Group

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Santa Maria : Central Coast Medical Oncology Corp

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Santa Monica : University of California, Los Angeles Medical Center (UCLA)

A clinical trial seeking patients for a research study for the treatment of Solid Tumors

Stanford : Stanford Cancer Center - Stanford University

Patients are needed to participate in a clinical research study evaluating CDX-1127

Whittier :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Colorado

Aurora : University of Colorado Cancer Center

A clinical research study of Ponatinib

Aurora : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Aurora : University of Colorado Anschutz Medical Campus

Patients are needed to participate in a clinical research study of IMMU-132

Denver : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Connecticut

Farmington : University of Connecticut Health Center

A Phase 2 clinical study for patients with Ovarian Neoplasms

Delaware

Newark : Helen F. Graham Cancer Center

Patients are needed to participate in a clinical research study of IMMU-132

District of Columbia

Washington : Research Site

A clinical research study of MEDI-565 for the treatment of Gastrointestinal Adenocarcinomas

Washington : Georgetown University

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Washington : Sibley Memorial Hospital Updated

A clinical trial to evaluate treatments using vorinostat, temsirolimus, laboratory biomarker analysis and positron emission tomography/computed tomography for patients

Florida

Boca Raton : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Fort Myers : Florida Cancer Specialists - South

A clinical trial to evaluate treatments using 5-Fluorouracil, Oxaliplatin, Lapatinib and Radiation Therapy for patients with Localized HER2 Positive Esophagogastric Cancer

Gainesville : Florida Cancer Specialists

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Jacksonville :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Jacksonville : Mayo Clinic Jacksonville

A clinical research study of Tumor markers for the treatment of Pancreatic Adenocarcinoma

Jacksonville : Mayo Clinic Florida

Patients are needed to participate in a clinical research study of Spectroscopy device to evaluate Pancreatic Adenocarcinoma

Orlando : Florida Hospital Cancer Institute

A clinical trial to evaluate treatments using 5-Fluorouracil, Oxaliplatin, Lapatinib and Radiation Therapy for patients with Localized HER2 Positive Esophagogastric Cancer

Orlando : MD Anderson Cancer Center Orlando

Patients are needed to participate in a clinical research study of IMMU-132

Pembroke Pines : Memorial Cancer Institute

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

Pensacola : Woodlands Medical Specialists

A clinical trial to evaluate treatments using 5-Fluorouracil, Oxaliplatin, Lapatinib and Radiation Therapy for patients with Localized HER2 Positive Esophagogastric Cancer

Pensacola : Sacred Heart Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Pensacola : Sacred Heart Medical Oncology Group - Davis Highway

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Sarasota : Florida Cancer Specialists / Sarah Cannon Research Institute

A clinical research study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody for the treatment of Malignant Solid Tumors

St. Petersburg : Florida Cancer Specialists

A clinical trial to evaluate treatments for patients with Colorectal Cancer

St. Petersburg : Florida Cancer Specialists-North

A clinical trial to evaluate treatments using 5-Fluorouracil, Oxaliplatin, Lapatinib and Radiation Therapy for patients with Localized HER2 Positive Esophagogastric Cancer

Tampa : H. Lee Moffitt Cancer Center & Research Institute Moffitt 4

A clinical research study of LDE225 and BKM120

Tampa : H. Lee Moffitt Cancer Center and Research Institute

A clinical trial seeking patients for a research study for the treatment of Rectal Cancer

Tampa : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Tampa : Moffitt Cancer Center

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Georgia

Savannah : Memorial University Medical Center

RTOG 1010: A Phase III Trial Evaluating the Addition of Trastuzumab to Trimodality Treatment of HER2-Overexpressing Esophageal Adenocarcinoma

Atlanta : Emory University

A clinical research study of CEP-37250/KHK2804 for the treatment of Solid Tumour, Adenocarcinoma of the Colorectal or Adenocarcinoma of the Pancreas

Atlanta : Piedmont Hospital Research Institute

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

Atlanta : Peachtree Hematology Oncology Consultants, PC

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Atlanta : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Augusta : Research Site

A clinical research study of MEDI-565 for the treatment of Gastrointestinal Adenocarcinomas

Gainesville : Northeast Georgia Medical Center

A clinical trial to evaluate treatments using 5-Fluorouracil, Oxaliplatin, Lapatinib and Radiation Therapy for patients with Localized HER2 Positive Esophagogastric Cancer

Lawrenceville : Suburban Hematology Oncology Associates, PC

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Savannah : Memorial Health University Medical Center

A clinical trial to evaluate treatments using live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001 and laboratory biomarker analysis for patients with Cervical Cancer

Illinois

Arlington Heights : Illinois Cancer Specialists Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Chicago : Northwestern University

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Chicago : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Chicago : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Zion : Cancer Treatment Centers of America (CTCA-Midwestern)

Patients are needed to participate in a clinical research study evaluating OVax: Autologous, DNP-Modified Ovarian Cancer Vaccine for the treatment of Adenocarcinoma of the Ovary

Indiana

Goshen : IU Health Goshen Cancer Center

Patients are needed to participate in a clinical research study of IMMU-132

Indianapolis : Indiana University Simon Cancer Center

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Indianapolis : IU Simon Cancer Center

Patients are needed to participate in a clinical research study evaluating porfimer sodium, endoscopic ultrasonography, photodynamic therapy and gemcitabine hydrochloride for the treatment of Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas or Stage III Pancreatic Cancer

South Bend : Northern Indiana Cancer Research Consortium

A Phase 2 clinical study for patients with Ovarian Neoplasms

Iowa

Iowa City : University of Iowa Hospitals and Clinics

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Maine

Augusta : Harold Alfond Center for Cancer Care

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Maryland

Baltimore : Johns Hopkins University-Sidney Kimmel Cancer Center

A clinical trial to evaluate treatments using live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001 and laboratory biomarker analysis for patients with Cervical Cancer

Baltimore : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Baltimore : The Sydney Kimmel Comprehensive Center at John Hopkins Updated

A clinical trial to evaluate treatments using vorinostat, temsirolimus, laboratory biomarker analysis and positron emission tomography/computed tomography for patients

Baltimore : Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

A Phase 1/Phase 2 clinical study for patients with Resectable Pancreatic Adenocarcinoma

Baltimore : Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

A Phase 2 clinical study for patients with Metastatic Pancreatic Cancer

Massachusetts

Boston : Dana Farber Cancer Institute Dana SC

A clinical research study of LDE225 and BKM120

Boston : Massachusetts General Hospital Dept. of Mass General Hospital

A clinical trial seeking patients for a research study for the treatment of Pancreatic Cancer

Boston : Dana Farber Cancer Institute

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Boston : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Boston : Massachusettes General Hospital

Patients are needed to participate in a clinical research study of IMMU-132

Rockland : Please Contact U.S. Medical Information Located in

A clinical trial seeking patients for a research study for the treatment of Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma

Michigan

Ann Arbor : University of Michigan University Hospital

A clinical trial to evaluate treatments using live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001 and laboratory biomarker analysis for patients with Cervical Cancer

Ann Arbor : University of Michigan

Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer

Detroit : Wayne State University/Karmanos Cancer Institute Wayne St

A Phase 1 clinical study for patients using LGK974

Grand Rapids : Grand Rapids Oncology Program

A clinical trial to evaluate treatments using 5-Fluorouracil, Oxaliplatin, Lapatinib and Radiation Therapy for patients with Localized HER2 Positive Esophagogastric Cancer

Kalamazoo : West Michigan Cancer Center

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Minnesota

Rochester : Mayo Clinic - Rochester Division of Hematology

A clinical research study of LDE225 and BKM120

Rochester : Mayo Clinic

A Phase 1 clinical study for patients with Advanced Pancreatic Cancer, Metastatic Pancreatic Cancer or Pancreatic Adenocarcinoma

Rochester : Mayo Clinic

Patients are needed to participate in a clinical research study evaluating CDX-1127

Woodbury : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Mississippi

Tupelo : Hematology and Oncology Associates at BridgePoint

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Missouri

Columbia : University of Missouri - Ellis Fischel

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

St. Joseph : Saint Joseph Oncology, Inc.

A clinical trial to evaluate treatments for patients with Colorectal Cancer

St. Louis : Research Site

A clinical trial seeking patients for a research study for the treatment of Renal Cell Adenocarcinoma, Clear Cell Renal Carcinoma, Clear Cell Renal Cell Carcinoma or Renal Cell Carcinoma

St. Louis : Washington University School of Medicine

A clinical trial to evaluate treatments using live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001 and laboratory biomarker analysis for patients with Cervical Cancer

St. Louis : Washington University School of Medicine

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Montana

Billings : Saint Vincent Healthcare

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Missoula : Montana Cancer Institute

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Nebraska

Lincoln : Southeast Nebraska Cancer Center

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Omaha : Nebraska Cancer Specialists, Methodist Estabrook Cancer Center

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

Omaha : UNMC Eppley Cancer Center at the University of Nebraska Medical Center

A clinical trial seeking patients for a research study of ADH-1, cisplatin, gemcitabine hydrochloride and laboratory biomarker analysis

Nevada

Henderson : Comprehensive Cancer Centers of Nevada

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Henderson : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Las Vegas : Comprehensive Cancer Centers of Nevada

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Las Vegas : HealthCare Partners Medical Group Oncology/Hematology-Tenaya

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Las Vegas : HealthCare Partners Medical Group Oncology/Hematology-San Martin

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

New Jersey

Basking Ridge : Memoral Sloan Kettering Cancer Center

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

Basking Ridge : Memorial Sloan-Kettering Cancer Center at Basking Ridge

A clinical trial to evaluate treatments using Regorafenib for patients with Metastatic Colorectal Adenocarcinoma

Basking Ridge : Memoral Sloan Kettering Cancer Center

A Phase 2 clinical study for patients with Esophageal Adenocarcinoma

New Mexico

Las Cruces : Memorial Medical Center-Las Cruces

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

New York

Buffalo : Roswell Park Cancer Institute

A clinical trial seeking patients for a research study for the treatment of Adenocarcinoma of the Pancreas, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer or Unspecified Adult Solid Tumor, Protocol Specific

Buffalo : Roswell Park Cancer Institute Updated

A clinical trial to evaluate treatments using vorinostat, temsirolimus, laboratory biomarker analysis and positron emission tomography/computed tomography for patients

Buffalo : Roswell Park Cancer Institute

Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer

Commack : Memorial Sloan-Kettering Cancer Center @ Suffolk

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

Commack : Memorial Sloan-Kettering Cancer Center at Commack

A clinical trial to evaluate treatments using Regorafenib for patients with Metastatic Colorectal Adenocarcinoma

Jamaica : Queens Cancer Center of Queens Hospital

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

New Hyde Park : Long Island Jewish Medical Center

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

New York : Weill Cornell Medical College

A clinical trial seeking patients for a research study for the treatment of Gastric Adenocarcinoma, Gastroesophageal Adenocarcinoma or Distal Esophageal Adenocarcinoma

New York : Memorial Sloan-Kettering Cancer Center 1275 York Avenue

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

New York : Memorial Sloan Kettering Cancer Center MSKCC - SC

A clinical trial seeking patients for a research study for the treatment of Pancreatic Cancer

New York : Weill Cornell Medical College

A clinical trial seeking patients for a research study for the treatment of Small Cell Prostate Cancer, Neuroendocrine Prostate Cancer or Prostate Adenocarcinoma Plus > 50% Immunohistochemical Staining for Neuroendocrine Markers

New York : New York University Clinical Cancer Center

A clinical trial to evaluate treatments for patients with Colorectal Cancer

New York : Memorial Sloan Kettering Cancer Center

A clinical trial to evaluate treatments using degarelix injection and androgen deprivation therapy for patients with Prostate Cancer or Prostatic Adenocarcinoma

New York : Memorial Sloan-Kettering Cancer Center

A clinical trial to evaluate treatments using Regorafenib for patients with Metastatic Colorectal Adenocarcinoma

New York : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

New York : Memorial Sloan Kettering Cancer Center

A Phase 2 clinical study for patients with Esophageal Adenocarcinoma

New York : Weill Cornell/New York Presbyterian Hospital

Patients are needed to participate in a clinical research study of IMMU-132

Rochester : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Rockville Centre : Memorial Sloan-Kettering at Mercy Medical Center

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

Rockville Centre : Memorial Sloan-Kettering Cancer Center at Mercy Medical Center

A clinical trial to evaluate treatments using Regorafenib for patients with Metastatic Colorectal Adenocarcinoma

Sleepy Hollow : Memoral Sloan Kettering Cancer Center@Phelps Memorial Hospital

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

Sleepy Hollow : Memorial Sloan-Kettering Cancer Center Sleepy Hollow

A clinical trial to evaluate treatments using Regorafenib for patients with Metastatic Colorectal Adenocarcinoma

North Carolina

Chapel Hill : University of North Carolina at Chapel Hill

A clinical study for patients with Barrett's Esophagus, Intestinal Metaplasia or Intramucosal Adenocarcinoma

Chapel Hill : UNC - Chapel Hill

A clinical research study of CEP-37250/KHK2804 for the treatment of Solid Tumour, Adenocarcinoma of the Colorectal or Adenocarcinoma of the Pancreas

Chapel Hill : University of North Carolina

Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer

Chapel Hill : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Charlotte : Carolinas Medical Center

A clinical trial to evaluate treatments using live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001 and laboratory biomarker analysis for patients with Cervical Cancer

Durham : Duke University Medical Center Duke - Baker

A clinical research study of LDE225 and BKM120

Durham : Research Site

A clinical research study of MEDI-565 for the treatment of Gastrointestinal Adenocarcinomas

Greensboro : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Winston-Salem : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Ohio

Canton :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Cincinnati : Oncology Hematology Care, Inc.

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Cincinnati : Oncology Hematology Care

A clinical trial to evaluate treatments using 5-Fluorouracil, Oxaliplatin, Lapatinib and Radiation Therapy for patients with Localized HER2 Positive Esophagogastric Cancer

Cincinnati : Oncology Hematology Care Inc. Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Cleveland : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Cleveland : Case Western Reserve University

A clinical trial to evaluate treatments using live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001 and laboratory biomarker analysis for patients with Cervical Cancer

Columbus : The Ohio State University

A clinical research study of CEP-37250/KHK2804 for the treatment of Solid Tumour, Adenocarcinoma of the Colorectal or Adenocarcinoma of the Pancreas

Columbus : Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center

A clinical trial to evaluate treatments using panitumumab, irinotecan hydrochloride, fluorouracil and leucovorin calcium for patients

Columbus : Ohio State University Medical Center

Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer

Columbus : The Ohio State University Comprehensive Cancer Center

Patients are needed to participate in a clinical research study evaluating CDX-1127

Mentor : Lake University Ireland Cancer Center

A clinical trial to evaluate treatments using live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001 and laboratory biomarker analysis for patients with Cervical Cancer

Middletown : Signal Point Clinical Research Center, LLC

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Wilmington : Oncology Hematology Care, Inc.

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Oklahoma

Lawton : Cancer Centers of Southwest Oklahoma, LLC - Lawton

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Oklahoma City : University of Oklahoma Health Sciences Center

A clinical trial to evaluate treatments using live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001 and laboratory biomarker analysis for patients with Cervical Cancer

Tulsa : Cancer Treatment Centers of America (CTCA-Southwestern)

Patients are needed to participate in a clinical research study evaluating OVax: Autologous, DNP-Modified Ovarian Cancer Vaccine for the treatment of Adenocarcinoma of the Ovary

Oregon

Corvallis : Good Samaritan Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Eugene : Willamette Valley Clinical Studies Williamette Valley Cancer

A clinical research study of LDE225 and BKM120

Portland : Northwest Cancer Specialists Main Site

A clinical research study of LDE225 and BKM120

Portland : Kaiser Permanente Northwest Region Oncology Hematology

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Portland : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Portland : Oregon Health and Science University

Patients are needed to participate in a clinical research study evaluating CDX-1127

Pennsylvania

Gettysburg : Adams Cancer Center

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Philadelphia : Fox Chase Cancer Center FCCC

A clinical research study of LDE225 and BKM120

Philadelphia : Research Site

A clinical research study of MEDI-565 for the treatment of Gastrointestinal Adenocarcinomas

Philadelphia : University of Pennsylvania

A Phase 2 clinical study for patients with Metastatic Pancreatic Cancer

Philadelphia : Thomas Jefferson University

Patients are needed to participate in a clinical research study evaluating Cabazitaxel, Intensity Modulated Radiation Therapy (IMRT), Anti-Androgen Therapy: Bicalutamide and Luteinizing Hormone-Releasing Hormone (LHRH) Agonist for the treatment of Prostate Cancer

Philadelphia : Cancer Treatment Centers of America (ERMC)

Patients are needed to participate in a clinical research study evaluating OVax: Autologous, DNP-Modified Ovarian Cancer Vaccine for the treatment of Adenocarcinoma of the Ovary

Philadelphia : Thomas Jefferson University

Patients are needed to participate in a clinical research study of Alisertib, Abiraterone acetate and Prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

Philadelphia : Thomas Jefferson University Updated

Patients are needed to participate in a clinical research study of Enzalutamide, Goserelin acetate, Leuprolide acetate and Radiation therapy

Pittsburgh : University of Pittsburgh Cancer Institute

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

Pittsburgh : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Pittsburgh : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

York : WellSpan Health-York Hospital

Patients are needed to participate in a clinical research study of enzalutamide, abiraterone and prednisone to evaluate Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer or Stage IV Prostate Cancer

South Carolina

Charleston : Medical University of South Carolina

A clinical research study of vacc. w/ Poly-ICLC & peptide-pulsed dendritic cells for the treatment of Metastatic Pancreatic Cancer

Charleston : Medical Universtiy of South Carolina (MUSC)

A clinical trial seeking patients for a research study for the treatment of Solid Tumors

Columbia : South Carolina Oncology Associates

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Greenville : Gynecologic Oncology Research & Development, LLC

A clinical research study of Docetaxel and Carboplatin for the treatment of Advanced Endometrial Adenocarcinoma, Stage III A, B, C

Tennessee

Chattanooga : Chattanooga Oncology and Hematology Associates

A clinical trial to evaluate treatments using 5-Fluorouracil, Oxaliplatin, Lapatinib and Radiation Therapy for patients with Localized HER2 Positive Esophagogastric Cancer

Chattanooga : Tennessee Oncology - Chattanooga Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Knoxville :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Nashville : Tennessee Oncology

A clinical research study of MORAb-066

Nashville : Tennessee Oncology, PLLC

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Nashville : Tennessee Oncology

A clinical trial to evaluate treatments using 5-Fluorouracil, Oxaliplatin, Lapatinib and Radiation Therapy for patients with Localized HER2 Positive Esophagogastric Cancer

Nashville : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Nashville : Tennessee Oncology PLLC Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Nashville : Sarah Cannon Research Institute

Patients are needed to participate in a clinical research study evaluating CDX-1127

Texas

Bedford : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Dallas : Mary Crowley Cancer Center

A clinical research study of CEP-37250/KHK2804 for the treatment of Solid Tumour, Adenocarcinoma of the Colorectal or Adenocarcinoma of the Pancreas

Dallas : Sammons Cancer Center - Texas Oncology SC-2

A clinical research study of LDE225 and BKM120

Dallas : Texas Oncology, P.A. SC

A clinical research study of LDE225 and BKM120

Dallas : University of Texas Southwestern Medical Center at Dallas

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Dallas : University of Texas Southwestern Medical Center

A clinical trial to evaluate treatments using live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001 and laboratory biomarker analysis for patients with Cervical Cancer

Dallas : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Dallas : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Dallas : Mary Crowley Cancer Research Centers - Medical City

Patients are needed to participate in a clinical research study evaluating CDX-1127

Fort Worth : Center for Cancer and Blood Disorders, PC

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Fort Worth : Center for Cancer and Blood Disorders Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Galveston : University of Texas Medical Branch at Galveston

A clinical trial to evaluate treatments using live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001 and laboratory biomarker analysis for patients with Cervical Cancer

Houston : UT MD Anderson Cancer Center Updated

A clinical research study of Abraxane for the treatment of Colorectal Cancer or Cancer of Gastrointestinal Tract

Houston : Department of Investigator Cancer Therapeutics, University of Texas, MD Anderson Cancer Center

A clinical research study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody for the treatment of Malignant Solid Tumors

Houston : University of Texas/MD Anderson Cancer Center SC-3

A clinical research study of LDE225 and BKM120

Houston : University of Texas/MD Anderson Cancer Center MD Anderson 2

A Phase 1 clinical study for patients using LGK974

Houston : UT MD Anderson Cancer Center

A Phase 2 clinical study for patients with Gastrointestinal Cancer

Houston : UT MD Anderson Cancer Center

Patients are needed to participate in a clinical research study evaluating Capecitabine, Oxaliplatin and Bevacizumab for the treatment of Gastrointestinal Cancers

Houston : The University of Texas M. D. Anderson Cancer Center

Patients are needed to participate in a clinical research study of Spectroscopy device to evaluate Pancreatic Adenocarcinoma

Lubbock : Joe Arrington Cancer Research and Treatment Center

A clinical trial to evaluate treatments for patients with Colorectal Cancer

San Antonio : Cancer Therapy and Research Center (CTRC), The University of Texas Health Science Center at San Antonio

A clinical research study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody for the treatment of Malignant Solid Tumors

San Antonio : Novartis Investigative Site

A Phase 2 clinical study for patients with Cachexia

Weatherford : The Center for Cancer and Blood Disorders

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Utah

Salt Lake City : University of Utah / Huntsman Cancer Institute Huntsman

A clinical research study of LDE225 and BKM120

Salt Lake City : University of Utah / Huntsman Cancer Institute Huntsman UT

A clinical trial seeking patients for a research study for the treatment of Pancreatic Cancer

Salt Lake City : Utah Cancer Specialists

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Virginia

Charlottesville : University of Virginia Health System

Patients are needed to participate in a clinical research study evaluating CDX-1127

Midlothian : Virginia Cancer Institute

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Richmond : Virginia Cancer Institute

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Roanoke : Carilion GYN Oncology Associates

A clinical research study of Docetaxel and Carboplatin for the treatment of Advanced Endometrial Adenocarcinoma, Stage III A, B, C

Washington

Seattle : Swedish Medical Center Cancer Institute

A clinical research study of AUY922 and Cetuximab

Seattle : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Seattle : Virginia Mason Cancer Center

Patients are needed to participate in a clinical research study of IMMU-132

Tacoma : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Wisconsin

Milwaukee : Medical College of Wisconsin

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

Argentina

Ciudad Autonoma de Buenos Aires : Instituto de Oncologia Angel H. Roffo

A clinical research study of CIGB300 for the treatment of Squamous Cell Carcinoma of the Cervix or Adenocarcinoma of the Cervix

Australia

Bentleigh East : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Campbelltown : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Coffs Harbour : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Douglas : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Elizabeth Vale : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Heidelberg : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Heidelberg : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Kurralta Park : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Kurralta Park : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Murdoch : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Randwick : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Ringwood East : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

St Leonards : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Tamworth : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Tweed Heads : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Tweed Heads : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Woolloongabba : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Austria

Graz : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Innsbruck : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Kufstein : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Linz : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Linz : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Salzburg : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Vienna : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Vienna : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Belgium

Brussels : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Brussels : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Brussels : Novartis Investigative Site

Patients are needed to participate in a clinical research study of RAD001

Bruxelles : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Bruxelles : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Bruxelles : Hôpital Erasme

Patients are needed to participate in a clinical research study of Spectroscopy device to evaluate Pancreatic Adenocarcinoma

Charleroi : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Charleroi : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Edegem : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Edegem : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Gent : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Gent : Novartis Investigative Site

Patients are needed to participate in a clinical research study of RAD001

Haine St. Paul : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Jette : AZ VUB

A Phase 2 clinical study for patients with Lung Neoplasms, Non-Small Cell Lung Cancer or Adenocarcinoma, Bronchiolo-Alveolar

Leuven : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Liege : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Liège : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Roeselare : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Wilrijk : Novartis Investigative Site

A clinical research study of LDE225 and BKM120

Yvoir : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Bosnia and Herzegovina

Banja Luka : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Sarajevo : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Sarajevo : Synta Pharmaceuticals Investigative Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Tuzla : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Brazil

Sao Paulo : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Bulgaria

Plovdiv : Multiprofile Hospital for Active Treatment "Central Onco Hospital", Plovdiv, Department of Medical Oncology

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Plovdiv : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Shumen : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Sofia : Multiprofile Hospital for Active Treatment "Serdika", Sofia, Department of Medical Oncology

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Sofia : Military Medical Academy - Multiprofile Hospital for Active Treatment, Sofia, Department of Medical Oncology

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Sofia : University Multiprofile Hospital for Active Treatment "Tsaritsa Yoanna - ISUL", Sofia, Clinic of Medical Oncology

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Sofia : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Sofia : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Sofia : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Sofia : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Varna : Multiprofile Hospital for Active Treatment "Sveta Marina", Varna, Clinic of Medical Oncology

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Varna : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Canada

Edmonton : Cross Cancer Institute

A clinical research study of Irinotecan-Capecitabine-Oxaliplatin for the treatment of Gastrointestinal Neoplasm or Gastric Adenocarcinoma

Edmonton : Novartis Investigative Site

A clinical research study of LDE225 and BKM120

Edmonton : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Greenfield Park : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Laval : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

London : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Montreal : Jewish General Hospital

A clinical research study of Androgen suppression plus radiation therapy for the treatment of Adenocarcinoma of the Prostate

Montreal : Montreal General Hospital

A clinical research study of Androgen suppression plus radiation therapy for the treatment of Adenocarcinoma of the Prostate

Montreal : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Toronto : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Toronto : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Toronto : Princess Margaret Hospital

Patients are needed to participate in a clinical research study evaluating AUY922 for the treatment of Adenocarcinoma of the Pancreas or Metastatic Disease

Vancouver : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

China

Beijing : Chinese People's Liberation Army (PLA) General Hospital

A clinical trial seeking patients for a research study for the treatment of EGFR Positive Non-small Cell Lung Cancer or Adenocarcinoma

Beijing : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Beijing : Peking Unicersity Cancer Hospital

A Phase 3 clinical study for patients with Advanced Gastric Carcinoma

Beijing : Department of GI Oncology, Peking University, School of Oncology

Patients are needed to participate in a clinical research study evaluating Paclitaxel, capecitabine and cisplatin for the treatment of Advanced Gastric Cancer

Beijing : Beijing Cancer Hospital

Patients are needed to participate in a clinical research study of SOX sequential S-1 to evaluate Biliary Tract Cancer, Periampullary Adenocarcinoma or Pancreatic Cancer

Changchun : The First Bethune Hospital of Jilin Univercity

A Phase 3 clinical study for patients with NSCLC

Changsha : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Changzhou : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Chengdu : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Chengdu : Sichuan Provincal Tumor Hospital

A Phase 3 clinical study for patients with NSCLC

Chengdu City : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Chongqing : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Foshan City : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Guangzhou : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Hangzhou : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Hangzhou City : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Harbin : Harbin Medical Univercity Cancer Hospital

A Phase 3 clinical study for patients with NSCLC

Nanjing : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Shanghai : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Shenyang : The First Hospital of China Medical University

A Phase 3 clinical study for patients with NSCLC

Shijiazhuang : Hebei Provincal Tumor Hospital

A Phase 3 clinical study for patients with NSCLC

Suzhou City : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Taiyuan : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Wuhan City : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Xian : Xijing Hospital

A Phase 3 clinical study for patients with NSCLC

Zhengzhou : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Zhengzhou : Henan Provincal Tumor Hospital

A Phase 3 clinical study for patients with NSCLC

Croatia

Zagreb : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Czech Republic

Horovice : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Hradec Kralove : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Olomouc : University Hospital Olomouc, Clinic of Oncology

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Olomouc : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Olomouc : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Ostrava : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Prague : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Prague : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Prague : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Praha 2 : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Usti nad Labem : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Znojmo : Hospital Znojmo, Department of Radiation and Clinical Oncology

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Denmark

Aalborg : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Århus C : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Copenhagen : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Odense : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Finland

Kuopio : Kuopio University Hospital

Patients are needed to participate in a clinical research study evaluating docetaxel and capecitabine for the treatment of Stomach Neoplasms

Oulu : Oulu Univerity Hospital

Patients are needed to participate in a clinical research study evaluating docetaxel and capecitabine for the treatment of Stomach Neoplasms

Tampere : University of Tampere

Patients are needed to participate in a clinical research study evaluating docetaxel and capecitabine for the treatment of Stomach Neoplasms

Turku : Department of Oncology and Radiotherapy, turku University Hospital

Patients are needed to participate in a clinical research study evaluating docetaxel and capecitabine for the treatment of Stomach Neoplasms

Vaasa : Vaasa Distric Hospital

Patients are needed to participate in a clinical research study evaluating docetaxel and capecitabine for the treatment of Stomach Neoplasms

France

Bayonne : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Bordeaux : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Clermont Ferrand : Centre Hospitalier Universitaire Estaing

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Clermont Ferrand Cedex 1 : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Creteil : Hopital Henri Mondor

A clinical trial seeking patients for a research study for the treatment of Adenocarcinoma of Prostate

Dijon : Centre Georges François Leclerc

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Le Mans : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Lille Cedex : Centre Oscar Lambret, Dept. de Cancerologie Digestive et Urologique

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Limoges Cedex : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Lyon Cedex 03 : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Marseille cedex 5 : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Marseille cedex 5 : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Montpellier Cedex 5 : Centre Hospitalier Régional Universitaire Hôpital Saint Eloi

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Nice Cedex 2 : Centre Antoine Lacassagne

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Nice cedex 2 : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Périgueux cedex : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Reims : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Rennes Cedex : Institut Paoli Calmettes Centre Régional de Lutte Contre le Cancer

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Rennes Cedex : Centre Eugène Marquis

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Saint Priest en Jarez : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Saint Priest en Jarez Cedex : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Strasbourg : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Tours : Hôpital Trousseau - Service de Gastroenterologie

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Villejuif : Research Site

A clinical trial seeking patients for a research study for the treatment of Renal Cell Adenocarcinoma, Clear Cell Renal Carcinoma, Clear Cell Renal Cell Carcinoma or Renal Cell Carcinoma

Germany

Bad Nauheim : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Berlin : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Berlin : Charité - Universitätsmedizin Berlin Charité Centrum für Tumormedizin

A Phase 1/Phase 2 clinical study for patients with Carcinoma, Pancreatic Ductal

Berlin : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Bielefeld : Onkologische Schwerpunktpraxis Bielefeld

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Bielefeld : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Bochum : Medizinische Universitätsklinik Bochum

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Bochum : Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Bochum : Universitätsklinikum Knappschaftskrankenhaus Bochum

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Brandenburg : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Braunschweig : Prof. Dr. F. Lordick

A clinical research study of catumaxomab, Fluorouracil, leucovorin, oxaliplatin, docetaxel and Fluorouracil, leucovorin, oxaliplatin, docetaxel for the treatment of Gastric Adenocarcinoma With Peritoneal Carcinomatosis, Siewert Type II Adenocarcinoma of Esophagogastric Junction With Peritoneal Carcinomatosis or Siewert Type III Adenocarcinoma of Esophagogastric Junction With Peritoneal Carcinomatosis

Chemnitz : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Cologne : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Cottbus : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Darmstadt : Please Contact Merck Communication Services Located in

A clinical trial seeking patients for a research study for the treatment of Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma

Darmstadt, Germany : Please contact Merck KGaA Communication Center located in

A clinical research study of MEK Inhibitor MSC1936369B, Gemcitabine and Placebo and Gemcitabine and MEK Inhibitor MSC1936369B for the treatment of Pancreatic Adenocarcinoma

Dortmund : Klinikum Dortmund gGmbH Medizinische Klinik Mitte

A Phase 1/Phase 2 clinical study for patients with Carcinoma, Pancreatic Ductal

Dresden : Universitätsklinikum Dresden

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Dresden : BAG / Onkologische Schwerpunktpraxis

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Dresden : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Dresden : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Elstra : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Essen : Novartis Investigative Site

A clinical research study of LDE225 and BKM120

Essen : Universitätsklinikum Essen

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Essen : Universitätsklinikum Essen, Innere Klinik Tumorforschung

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Essen : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Frankfurt : Städtisches Klinikum Frankfurt-Höchst

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Frankfurt : Institut für Klinische Forschung, Krankenhaus Nordwest GmbH

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Frankfurt am Main : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Freiburg : Universitätsklinikum Freiburg, Innere Medizin II

A Phase 1/Phase 2 clinical study for patients with Carcinoma, Pancreatic Ductal

Freital : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Fürstenwalde : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Gauting : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Halle/Saale : Universitätsklinikum Halle/Saale; Poliklinik für innere Medizin iV

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Halle/Saale : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Hamburg : Katholisches Marienkrankenhaus gGmbH

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Hannover : Klinikum Region Hannover GmbH, Krankenhaus Siloah

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Heidelberg : Research Site

A clinical trial seeking patients for a research study for the treatment of Renal Cell Adenocarcinoma, Clear Cell Renal Carcinoma, Clear Cell Renal Cell Carcinoma or Renal Cell Carcinoma

Herne : Medizinische Klinik III - Hämatologie/Onkologie Marienhospital Herne

A Phase 1/Phase 2 clinical study for patients with Carcinoma, Pancreatic Ductal

Jena : Universitätsklinikum der Friedrich-Schiller-Universität Jena

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Kassel : Klinikum Kassel GmbH Medizinischen Klinik IV;Onkologie,

A Phase 1/Phase 2 clinical study for patients with Carcinoma, Pancreatic Ductal

Köthen : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Kronach : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Lebach : Gemeinschaftspraxis für Hämatologie und Onkologie

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Leipzig :

A clinical research study for the treatment of Non-Small Cell Lung Cancer

Leipzig : Universitätsklinikum Leipzig, Klinik und Poliklinik für Gastroenterologie und Rheumatologie

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Leipzig : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Leipzig : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Leipzig : Hospital

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Leubeck : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Magdeburg : University Magdeburg

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Magdeburg : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Magdeburg : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Mainz : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Mannheim : Universitätsklinikums Mannheim

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Meiningen : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Mühlhausen : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

München : Ludwig-Maximilians-Universität München Klinikum Großhadern

A clinical trial to evaluate treatments for patients with Colorectal Cancer

München : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

München : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Munich : University of Munich

Patients are needed to participate in a clinical research study for the treatment of Metastatic Pancreatic Adenocarcinoma

Münster : Hämatologisch-Onkologische Gemeinschaftspraxis

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Nürnberg : Klinikum Nürnberg Nord Medizinische Klinik 5

A Phase 1/Phase 2 clinical study for patients with Carcinoma, Pancreatic Ductal

Oldenburg : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Parchim : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Pinneberg : Onkologische Schwerpunktpraxis Pinneberg

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Plauen : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Regensburg : Klinik und Poliklinik für Innere Medizin I Universitätsklinikum Regensburg

A Phase 1/Phase 2 clinical study for patients with Carcinoma, Pancreatic Ductal

Rostock : Universitätsklinikum Rostock

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Scheibenberg : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Schweinfurt : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Stuttgart : Klinikum Stuttgart Klinik Hämatologie, Onkologie und Palliativmedizin

A Phase 1/Phase 2 clinical study for patients with Carcinoma, Pancreatic Ductal

Torgau : Clinic

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Trier : Krankenanstalt Mutterhaus der Borromäerinnen e.V.

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Ulm : Universitätsklinikum Ulm

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Ulm : Universitätsklinikum Ulm Zentrum für Innere Medizin

A Phase 1/Phase 2 clinical study for patients with Carcinoma, Pancreatic Ductal

Werdau : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Zittau : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Zwickau : Practice

Patients are needed to participate in a clinical research study for the treatment of Carcinoma

Greece

Athens : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Athens : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Athens : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Heraklion : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Heraklion : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Larissa : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Nea Kifissia, Athens : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Patra : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Thessaloniki : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Thessaloniki : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Hong Kong

Hong Kong :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Sha Tin :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Hungary

Budapest : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Budapest : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Budapest : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Deszk : Synta Pharmaceuticals Investigative Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Gyor : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Nyiregyhaza : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Szeged : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Szekesfehervar : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Szolnok : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Indonesia

Jakarta : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Surabaya : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Israel

Haifa : Rambam medical Center

A clinical trial to evaluate treatments using Capecitabine (Xeloda) for patients with Adenocarcinoma Clear Cell

Italy

Ancona : Novartis Investigative Site

A clinical research study of LDE225 and BKM120

Aviano PN : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Brescia : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Catania : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Firenze : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Firenze : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Lido di Camaiore : Ospedale Unico Versilia

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Milano : Novartis Investigative Site

A clinical research study of LDE225 and BKM120

Milano : Istituto Europeo di Oncologia

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Milano : Ospedale Niguarda Cà Granda

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Monza : Azienda Ospedaliera San Gerardo di Monza

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Napoli : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Pisa : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Reggio Emilia : Arcispedale Santa Maria Nuova IRCCS

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Roma : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Rome : Università Cattolica del Sacro Cuore

Patients are needed to participate in a clinical research study of Spectroscopy device to evaluate Pancreatic Adenocarcinoma

Rozzano MI : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Sassari : Ospedale Civile SS Annunziata ASL 1

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Torino : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Japan

Chuo-ku :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Fukuoka-shi : Kyushu University

A clinical research study of Tumor markers for the treatment of Pancreatic Adenocarcinoma

Kobe :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Nagoya :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Osaka-Sayama :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Korea, Republic of

Cheongju : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Dong-gu : Ulsan University Hospital

A clinical research study of NOV120101 (Poziotinib) for the treatment of Adenocarcinoma of Lung Stage IIIB or Adenocarcinoma of Lung Stage IV

Gangnam-gu : Samsung Medical Center

A clinical research study of NOV120101 (Poziotinib) for the treatment of Adenocarcinoma of Lung Stage IIIB or Adenocarcinoma of Lung Stage IV

Goyang-si : National Cancer Center

A clinical research study of NOV120101 (Poziotinib) for the treatment of Adenocarcinoma of Lung Stage IIIB or Adenocarcinoma of Lung Stage IV

Goyang-si : National Cancer Center

Patients are needed to participate in a clinical research study evaluating Gefitinib, Placebo and Pemetrexed plusCIsplatin for the treatment of Non Small Cell Lung Cancer or Adenocarcinoma

Jongno-gu : Seoul National University Hospital

A clinical research study of NOV120101 (Poziotinib) for the treatment of Adenocarcinoma of Lung Stage IIIB or Adenocarcinoma of Lung Stage IV

Namdong-Gu : Gachon University Gil Hospital

A clinical research study of NOV120101 (Poziotinib) for the treatment of Adenocarcinoma of Lung Stage IIIB or Adenocarcinoma of Lung Stage IV

Seoul : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Songpa-gu : Asan Medical Center

A clinical research study of NOV120101 (Poziotinib) for the treatment of Adenocarcinoma of Lung Stage IIIB or Adenocarcinoma of Lung Stage IV

Latvia

Daugavpils : Daugavpils Regional Hospital

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Liepaja : Piejuras Hospital, Oncology Clinic

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Riga : Riga East University Hospital, LLC

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Malaysia

Kuala Lumpur : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Mexico

Cuernavaca : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Distrito Federal : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Mexico : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Toluca : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Netherlands

Amsterdam : Nederlands Kanker Instituut/Antonie van Leeuwenhoek Ziekenhuis

A clinical research study of Surgical resection

Amsterdam : Academic Medical Center

Patients are needed to participate in a clinical research study to evaluate Barrett'S-associated Dysplasia or Intramucosal Adenocarcinoma

Rotterdam : Novartis Investigative Site

A Phase 1 clinical study for patients using LGK974

Poland

Bialystok : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Bydgoszcz : Centrum Onkologii im. Prof. Franciszka Lukaszczyka w Bydgoszczy

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Elblag : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Gdansk : Uniwersyteckie Centrum Kliniczne

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Gdansk : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Konin : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Konin : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Kraków : Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie, Spólka z o. o.

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Lodz : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Olsztyn : Olsztynski Osrodek Onkologiczny "Kopernik" sp. z o. o.

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Otwock : Novartis Investigative Site

Patients are needed to participate in a clinical research study of RAD001

Poznan : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Prabuty : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Szczecin : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Warsaw : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Warszawa : Centrum Onkologii - Instytut im Marii Sklodowskiej-Curie

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Warszawa : Centralny Szpital Kliniczny MSWiA

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Warszawa : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Warszawa : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Portugal

Aveiro : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Guimaraes : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Lisboa : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Porto : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Santa Maria da Feira : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Vila Real : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Romania

Alba Iulia : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Baia Mare : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Brasov : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Bucharest : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Bucharest : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Bucharest : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Bucharest : Novartis Investigative Site

A Phase 2 clinical study for patients with Cachexia

Bucharest : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Bucharest : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Bucharest : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Cluj Napoca : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Cluj Napoca : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Cluj Napoca : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Cluj-Napoca : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Cluj-Napoca : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Cluj-Napoca : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Craiova : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Iasi : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Lasi : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Timisoara : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Timisoara : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Russian Federation

Arkhangelsk : State Institution of Healthcare "Arkhangelsk Regional Clinical Oncology Dispensary"

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Arkhangelsk : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Arkhangelsk : Arkhangelsk Clinical Oncology Center

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Barnaul : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Belgorod : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Birobidzhan : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Bryansk : Bryansk Regional Oncology Center

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Chelyabinsk : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Chelyabinsk : Chelyabinsk Regional Clinical Oncology Center

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Chelyabinsk : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Chelyabinsk : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Chita : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Ekaterinburg : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Irkutsk : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Ivanovo : Ivanovo Regional Oncology Center

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Ivanovo : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Ivanovo : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Izhevsk : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Izhevsk : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Kazan : Republican Clinical Oncologic Dispensary of Ministry of health of Republic Tatarstan

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Kazan : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Kazan : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Kemerovo : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Kemerovo : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Khabarovsk : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Khanty-Mansisk : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Krasnodar : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Krasnodar : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Krasnodar : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Krasnoyarsk : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Krasnoyarsk : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Kursk : Kursk Regional Oncologic Dispensary

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Kursk : Kursk Regional Clinical Oncology Center

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Kursk : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Lipetsk : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Lipetsk : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Moscow : Cancer Research Center n.a. Blokhin, Chemotherapy Dept.

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Moscow : State Institution "Blokhin Cancer Research Centre RAMS"

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Moscow : Non-State Institution of healthcare "Central Clinical Hospital #1 OAO RZD"

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Moscow : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Moscow : Blokhin Russian Oncology Research Center

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Moscow : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Moscow : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Nizhny Novgorod : Nizhny Novgorod City Oncology Dispensary

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Nizhny Novgorod : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Novgorod : Regional Clinical Oncology Center

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Novosibirsk : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Novosibirsk : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Obninsk : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Obninsk : Medical Radiology Research Center

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Omsk : State Healthcare Institution of Omsk Region "Clinical Oncologic Dispensary"

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Omsk : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Omsk : Clinical Oncology Center

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Omsk : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Orel : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Orel : Orel Oncology Center

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Orel : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Orenburg : Orenburg Regional Clinical Oncology Center

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Pyatigorsk : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Pyatigorsk : Pyatigorsk Oncology Center

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Rostov-on-Don : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Rostov-on-Don : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Ryazan : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Ryazan : Ryazan Regional Clinical Oncology Center

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Saint Petersburg : N.N.Petrov Research Institute of Oncology

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Saint-Petersburg : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Samara : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Samara : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Samara : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Saransk : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Sochi : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

St. Petersburg : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

St. Petersburg : First Pavlov State Medical University of St. Petersburg

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

St. Petersburg : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

St. Petersburg : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

St. Petersburg : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

St.Petersburg : St. Petersburg Clinical Hospital

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

St.Petersburg : City Clinical Oncology Center

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

St.Petersburg : Nikiforov Russian Center for Emergency and Radiology Medicine

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Stavropol : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Surgut : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Tula : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Ufa : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Ufa : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Ufa : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Velikiy Novgorod : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Vladimir : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Vladivostok : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Volgograd : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Yakutsk : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Yaroslavl : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Yaroslavl : Regional Clinical Oncology Hospital

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Yuzhno-Sakhalinsk : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Serbia

Belgrade :

A clinical trial seeking patients for a research study for the treatment of Non-Small Cell Lung Cancer

Belgrade : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Belgrade : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Belgrade : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Knez Selo :

A clinical trial seeking patients for a research study for the treatment of Non-Small Cell Lung Cancer

Kragujevac : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Nis : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Sremska Kamenica :

A clinical trial seeking patients for a research study for the treatment of Non-Small Cell Lung Cancer

Sremska Kamenica : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Singapore

Singapore :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Singapore : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Slovakia

Bardejov : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Bratislava : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Poprad : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Trencin : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Slovenia

Golnik : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Ljubljana : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

South Africa

Cape Town : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Groenkloof : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Johannesburg : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Kraaifontein : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Pretoria : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Spain

A Coruña : Centro Oncológico Regional de Galicia

A clinical trial to evaluate treatments for patients with Colorectal Cancer

A Coruña : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Avila : Hospital Nuestra Señora de Sonsoles

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Badalona : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Barcelona : Novartis Investigative Site

A clinical research study of LDE225 and BKM120

Barcelona : Novartis Investigative Site

A clinical research study of LDE225 and BKM120

Barcelona : Hospital Universitario Vall d'Hebron

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Barcelona : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Barcelona : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Barcelona : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Barcelona : Novartis Investigative Site

A Phase 1 clinical study for patients using LGK974

Barcelona : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Barcelona : ACROSS

Patients are needed to participate in a clinical research study evaluating bevacizumab for the treatment of Rectal Neoplasms or Locally Advanced Rectal Adenocarcinoma

Elche : Hospital General Universitario de Elche

Patients are needed to participate in a clinical research study of NovoTTF-100L and Gemcitabine to evaluate Pancreatic Adenocarcinoma

Gerona : Hospital Universitario de Girona Doctor Josep Trueta

A clinical trial to evaluate treatments for patients with Colorectal Cancer

La Coruña : Centro Oncológico de Galícia

A clinical trial seeking patients for a research study for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma

L'Hospitalet de Llobregat : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

L'Hospitalet de Llobregat, Barcelona : Institut Català d'Oncologia

A Phase 1 clinical study for patients with Locally Advanced Pancreatic Adenocarcinoma or Metastatic Pancreatic Adenocarcinoma

Madrid : Hospital Clinico Universitario San Carlos

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Madrid : Centro Integral Oncológico Clara Campal, Hospital de Madrid Norte-San Chinarro

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Madrid : Hospital Universitario 12 de Octubre

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Madrid : Instituto de Investigación Sanitaria

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Madrid : Hospital Universitario Ramón y Cajal

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Madrid : Hospital Universitario La Paz

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Madrid : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Madrid : Centro Integral Oncológico Clara Campal

A Phase 1 clinical study for patients with Locally Advanced Pancreatic Adenocarcinoma or Metastatic Pancreatic Adenocarcinoma

Madrid : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Madrid : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Madrid : Hospital Universitario Madrid Sanchinarro

Patients are needed to participate in a clinical research study of lurbinectedin (PM01183) and Doxorubicin to evaluate Endometrial Adenocarcinomas, Neuroendocrine Tumors or Small-cell Lung Cancer With Less Than 2 Prior Cytotoxic-containing Lines of Therapy)

Madrid : Hospital 12 de Octubre

Patients are needed to participate in a clinical research study of NovoTTF-100L and Gemcitabine to evaluate Pancreatic Adenocarcinoma

Madrid : Ramon Y Cajal

Patients are needed to participate in a clinical research study of NovoTTF-100L and Gemcitabine to evaluate Pancreatic Adenocarcinoma

Malaga : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Malaga : Hospital Universitario Carlos Haya

Patients are needed to participate in a clinical research study of NovoTTF-100L and Gemcitabine to evaluate Pancreatic Adenocarcinoma

Oviedo : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Pamplona : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Santander : Hospital Universitario Santander

Patients are needed to participate in a clinical research study of NovoTTF-100L and Gemcitabine to evaluate Pancreatic Adenocarcinoma

Sevilla : Research Site

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Terrassa : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Valencia : Hospital Clinico Universitario de Valencia

A clinical trial to evaluate treatments for patients with Colorectal Cancer

Sweden

Eskilstuna : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Stockholm : Dept. of Oncology-Pathology, Karolinska University Hospital, Solna Updated

A clinical trial to evaluate treatments using AXP107-11 for patients with Adenocarcinoma

Stockholm : Dept. of Clinical Science, Intervention and Technology, Div. of surgery, Karolinska University Hospital, Huddinge Updated

A clinical trial to evaluate treatments using AXP107-11 for patients with Adenocarcinoma

Stockholm : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Switzerland

Bellinzona : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Bern : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Chur : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Zurich : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Taiwan

Kaohsiung : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Tainan : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Taipei : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Thailand

Chiang Mai : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Khon Kaen : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Patumwan Bangkok : Research Site

A clinical trial to evaluate treatments using EGFR mutation test for patients with EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

Turkey

Ankara : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Gaziantep : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Istanbul : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Izmir : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Ukraine

Cherkasy : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Chernivtsi : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Dnepropetrovsk : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Dnipropetrovsk : Dnipropetrovsk City Multispecialty Clinical Hospital #4, Department of Chemotherapy

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Dnipropetrovsk : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Donetsk : Donetsk Regional Antitumor Center, Thoracic Department #2

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Donetsk : Donetsk Regional Antitumor Center, Oncosurgery Department #6D

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Donetsk : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Donetsk : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Ivano-Frankivsk : Regional Clinical Oncology Center, Department of Abdominal Surgery

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Ivano-Frankivsk : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Kharkiv : Kharkiv Regional Clinical Oncology Center, Abdominal Department

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Kharkiv : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Kharkiv : Synta Pharmaceuticals Investigative Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Kherson : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Khmelnytskyi : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Kirovohrad : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Kryvyi Rih : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Kyiv : Kyiv City Clinical Oncology Center, Department of Chemotherapy

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Kyiv : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Kyiv : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Lutsk : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Lviv : Lviv State Regional Treatment and Diagnostics Oncology Center, Department of Chemotherapy

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Lviv : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Makiivka : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Mariupol : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Poltava : Poltava Regional Clinical Oncology Center, Thoracic Department

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Poltava : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Simferopol : Clinical Diagnostics Center, LLC, Treatment and Diagnostics Center, Department of Oncology

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Simferopol : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Sumy : Sumy Regional Clinical Oncology Center, Oncothoracic Department

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Sumy : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Sumy : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Uzhgorod : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Uzhhorod : Zakarpattia Regional Clinical Oncology Center, Department of Chemotherapy

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

Uzhhorod : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Vinnytsia : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Zaporizhia : Zaporizhia Regional Clinical Oncology Center, Department of Surgery (Abdominal)

A clinical trial to evaluate treatments using Epirubicin, Oxaliplatin, Capecitabine and IMAB362 for patients with CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of Esophagus or CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

United Kingdom

Belfast : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Edinburgh : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Edinburgh : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Glasgow : Novartis Investigative Site

A clinical research study of LDE225 and BKM120

Guildford : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Leicester : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Leicester : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Liverpool : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Pancreatic Cancer

London : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

London : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

London : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

London : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

London : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

London : UCLH (University College London Hospitals)

Patients are needed to participate in a clinical research study of lurbinectedin (PM01183) and Doxorubicin to evaluate Endometrial Adenocarcinomas, Neuroendocrine Tumors or Small-cell Lung Cancer With Less Than 2 Prior Cytotoxic-containing Lines of Therapy)

Manchester : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Newcastle Upon Tyne : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Northwood : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Nottingham : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Nottingham : Nottingham Univeristy Hospitals NHS Trust

Patients are needed to participate in a clinical research study evaluating Iron isomaltoside 1000 for the treatment of Anemia, Esophageal Cancer or Gastric Cancer

Salisbury : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Southampton : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Sutton : Novartis Investigative Site

A clinical research study of LDE225 and BKM120

Sutton : Research Site

A clinical trial to evaluate treatments using Rilotumumab and Placebo for patients with Gastric Cancer

Sutton : Synta Pharmaceuticals Investigational Site

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

 

Kidney & Urology Foundation of America | 152 Madison Ave, Suite 201 | New York, NY 10016 | 1.800.633.6628
©

About Us | Patient Resources | Professional Resources | Support Us | News & Recent Events | Brochures
Corporate Sponsors | Contact Us | Terms of Use | Privacy Policy

Website Last Modified: October 28, 2010
Donate Today Donate Your Car Join KUFA Now